Home › NDC Lookup › RxCUI directory › RxCUI 1442170

Fenofibrate 90 MG Oral Capsule [Antara] — RxCUI 1442170

RxNorm drug concept · Semantic branded drug
RxCUI 1442170 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 0 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1442170
Official nameFenofibrate 90 MG Oral Capsule [Antara]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAntara 90 MG Oral Capsule
FDA products mapped2
Package NDCs mapped0
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fenofibrate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fenofibrate helps bring your blood lipid levels into a healthier range. Depending on your situation, that might mean lowering your triglycerides, bringing down your LDL (bad) chole...
  • What exactly is fenofibrate supposed to do for me?
  • It depends on which form you have. Lipofen capsules should be taken with food. Antara capsules and most fenofibrate tablets can be taken with or without food. Some film-coated feno...
  • Does it matter if I take this with food or on an empty stomach?
📖 Read our full Fenofibrate guide →

🕸️ Concept Web — How Fenofibrate 90 MG Oral Capsule [Antara] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fenofibrate 90 MG Oral Capsule [Antara] RxCUI 1442170

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fenofibrate 8703
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Antara 578784
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fenofibrate Oral Capsule 379815
    • Fenofibrate Oral Product 1159042
    • Fenofibrate Pill 1159043
    • Fenofibrate Oral Capsule [Antara] 578796
    • Antara Oral Product 1176848
    • Antara Pill 1165999
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fenofibrate 90 MG Oral Capsule SCD · 1442168
  • Fenofibrate 90 MG SCDC · 1442167
  • Fenofibrate Oral Capsule SCDF · 379815
  • Fenofibrate Oral Product SCDG · 1159042
  • Fenofibrate Pill SCDG · 1159043

Brand-Name Concepts

  • Fenofibrate 90 MG [Antara] SBDC · 1442169
  • Fenofibrate Oral Capsule [Antara] SBDF · 578796
  • Antara Oral Product SBDG · 1176848
  • Antara Pill SBDG · 1165999
  • Antara BN · 578784

📦 FDA Products & Package NDCs

2 products · 0 package NDCs
No package NDCs are mapped to this concept in the current snapshot. Missing rows here mean the openFDA export did not annotate a listing with this RxCUI — never that no product exists.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.